Health Professional Radio - Podcast

Dr. Sabrina Paganoni, M.D., Ph.D., Investigator at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Justin Klee, Co-Founder and Co-CEO of Amylyx Pharmaceuticals discuss ALS (amyotrophic lateral sclerosis or Lou Gerhig’s disease) and a new investigational treatment that has shown an ability for patients to retain function and independence longer. The findings from that study are now being published in a leading medical journal. ALS as a disease has been notoriously challenging for new drug development, and this represents a historic step forward.